Alhtough our study provides insight into dysregulated glia–neuron interactions and their downstream effects across two time points in a transgenic mouse model of AD, there are a few limitations, such as using a single AD mouse model and curated priors for CCC, GRN, and TF activity analyses. The gene discussed is GRN; the disease is Alzheimer disease.